Loading...

Search Results (761)

MatchTypeWhy
Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy.Academic Article Why?
Acetylated Tau Obstructs KIBRA-Mediated Signaling in Synaptic Plasticity and Promotes Tauopathy-Related Memory Loss.Academic Article Why?
Comparing Plasma Phospho Tau, Total Tau, and Phospho Tau-Total Tau Ratio as Acute and Chronic Traumatic Brain Injury Biomarkers.Academic Article Why?
Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy.Academic Article Why?
ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy.Academic Article Why?
Prion-like properties of Tau protein: the importance of extracellular Tau as a therapeutic target.Academic Article Why?
Soluble tau species, not neurofibrillary aggregates, disrupt neural system integration in a tau transgenic model.Academic Article Why?
Frontotemporal dementia with the V337M MAPT mutation: Tau-PET and pathology correlations.Academic Article Why?
Reversal of neurofibrillary tangles and tau-associated phenotype in the rTgTauEC model of early Alzheimer's disease.Academic Article Why?
Tau Antibody Targeting Pathological Species Blocks Neuronal Uptake and Interneuron Propagation of Tau in Vitro.Academic Article Why?
Removing endogenous tau does not prevent tau propagation yet reduces its neurotoxicity.Academic Article Why?
Phosphorylation of tau at Y18, but not tau-fyn binding, is required for tau to modulate NMDA receptor-dependent excitotoxicity in primary neuronal culture.Academic Article Why?
Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease.Academic Article Why?
Chemical Probes and Chaperone-Accelerated Turnover of TauGrant Why?
Mouse Models with Regulatable Cell Type-specific Expression of Anti-Tau shRNAsGrant Why?
Per Page    Page  of 51 Next
Prev
Search Criteria
  • tau
Search Result Filters
Back to TOP